WO1997041209A1 - Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits - Google Patents

Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits Download PDF

Info

Publication number
WO1997041209A1
WO1997041209A1 PCT/EP1997/002323 EP9702323W WO9741209A1 WO 1997041209 A1 WO1997041209 A1 WO 1997041209A1 EP 9702323 W EP9702323 W EP 9702323W WO 9741209 A1 WO9741209 A1 WO 9741209A1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
rabbit
embryonic stem
cell lines
generation
Prior art date
Application number
PCT/EP1997/002323
Other languages
French (fr)
Inventor
Randall Moreadith
Luc Schoonjans
Original Assignee
Leuven Research & Development Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leuven Research & Development Vzw filed Critical Leuven Research & Development Vzw
Priority to AU28929/97A priority Critical patent/AU2892997A/en
Priority to EP97922992A priority patent/EP0907722A1/en
Priority to JP9538604A priority patent/JP2000508919A/en
Publication of WO1997041209A1 publication Critical patent/WO1997041209A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877Techniques for producing new mammalian cloned embryos
    • C12N15/8777Rabbit embryos
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • C12N2501/235Leukemia inhibitory factor [LIF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/33Insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/13Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes

Definitions

  • the present invention relates to novel rabbit embryonic stem (ES) cell lines and their use in the gene ⁇ ration of chimeric rabbits.
  • Gene targeting via homologous recombination in embryonic stem (ES) cells) technology allows the manipulation of the genome in desired and defined ways (Capecchi, 1989; Robertson, 1987; Bradley, 1987) . Briefly, genes to be targeted are incorporated in plasmid transfer vectors and altered by replacement of some of their sequence with foreign DNA which encodes selectable markers (inactivation) or by a mutated gene sequence (targeted mutagenesis) . These inactivated or mutated genes are then introduced into ES cells (which each have the potential to develop into a complete animal) .
  • Completely ES cell derived mice can be generated utilising the recently developed technology to aggregate wild type or mutant ES cells with tetraploid embryos (Nagy et al . , 1993) .
  • ES cells can be used for introduction of genetic material by non- homologous recombination, allowing the study of genetic alteration in live animals.
  • transgenic technologies and ES cell technologies for the alteration of gene function has provided animal models of important human diseases (for review cfr. Wilson, 1996; Rubin and Barsch, 1996) .
  • this technology has only been successful in the mouse.
  • the mouse has significant restrictions (e.g. size and inability to generate the phenotype of human diseases) that limit its potential applications. Consequently, larger animal models to test the phenotypic consequences or loss-of-function mutations would be very valuable.
  • Presumptive pluripotential ES cells have been isolated in a number of additional species including hamster (Doetschman et al . , 1988) , pig (Evans et al . , 1990; Piedrahita et al . , 1990; Notarianni et al . , 1990; Talbot et al . , 1993) , sheep (Notarianni et al . , 1990) , cattle (Evans et al . ; Saito et al . , 1992) , mink (Sukoyan et al .
  • Inner cell mass (ICM) cells freshly derived from rabbit blastocysts have been shown to allow the generation of chimeric rabbits following injection into recipient blastocysts (Gardner and Munro, 1974; Moustafa, 1974; Babinet and Bordenave, 1980) , whereas Yang et al . (1993) have reported the production of chimeric rabbits both from freshly isolated ICM and from ICM cells maintained in culture in vitro for 3 days.
  • ES rabbit embryonic stem
  • ES cell line comprising at least 70%, preferably 80 to 90% undifferentiated cells is obtainable by isolating the inner cell mass of 5.5 days postcoitus blastocysts and culturing them on feeder cells in rabbit ES medium.
  • the rabbit ES medium according to the invention comprises high glucose Dulbecco' s Modified Eagle Medium, 4mM L-glutamine, 0.1 mM 2-mercaptoethanol, 148 units/ml penicillin G sodium, 148 microgram/ml streptomycin sulfate, 4 microgram/ml bovine insulin, 10 3 units/ml murine Leukemia Inhibitory Factor, 20% fetal bovine serum, 1.5% MEM non-essential amino acid solution.
  • the feeder cells are preferably mouse embryonic fibroblasts derived from 12.5 days old mouse embryos and used in a density of 3 to 4X10 6 cells per 10 cm petri dish.
  • a modified trypsinization method was used, which consists of the use of trypsinization medium comprising 0.1% collagenase, 1% chicken serum and 0.03% trypsin-EDTA in phosphate- buffered saline. This medium allowed the selective passage of ES cells because mouse embryonic fibroblasts and trophectodermal cells detach more slowly in this medium.
  • Cells according to the invention are recognisable by virtue of their following properties: three dimensional colony formation, positive staining for alkaline phosphatase and negative staining for cytokeratin 18 and vimentin after more than 10 passages.
  • the invention further relates to the use of the ES cell lines for the generation of chimeric rabbits, for example following blastocyst injection into recipient blastocysts or embryo aggregation or nuclear transfer.
  • the ES cell lines of the invention may also be used for gene alteration by homologous or non-homologous recombination or for the generation of rabbits with gene alteration via germline transmission.
  • the present invention thus leads to the improved derivation of pluripotent ES cells, their maintenance in culture over several passages, and their use for the successful generation of chimeric animals.
  • rabbit ES cells with demonstrated potential to generate chimeric rabbits following injection in recipient blastocysts will allow the generation of offspring capable of germline transmission of the targeted mutations following homologous or non-homologous recombination in these pluripotent ES cells.
  • the pluripotency of the rabbit ES cells will allow to differentiate them into defined cell types enabling the study or isolation of novel genes .
  • the invention will be illustrated in the following examples, that are not intended to limit the scope of the invention. Based on the present invention, several variants and improvements will be obvious to those skilled in the art .
  • the culture medium used by Graves and Moreadith (1993) consisted of high glucose Dulbecco's Modified Eagle Medium, 4mM L-glutamine, 0.1 mM 2-mercaptoethanol, penicillin G sodium l48U/ml, and streptomycin sulfate 148 ⁇ g/ml .
  • the following supplements were changed or added: 4 ⁇ g/ml bovine insulin, 10 3 units/ml of murine Leukemia Inhibitory Factor, 20% fetal bovine serum, 1.5% MEM non-essential amino acid solution.
  • the rabbit ES cells (1.5 to 3 X 10 6 cells per 10 cm petridish) were grown to subconfluency on mouse embryonic fibroblasts mitotically arrested with mitomycin and the ES cells were passaged every 4-6 days onto freshly prepared feeders (3 to 4 X 10 6 cells per 10 cm dish) .
  • the ES cells were fed every day with the improved medium described above.
  • Culture dishes were kept at 39°C in a humidified atmosphere of 5% C0 2 in air.
  • the mouse embryonic fibroblast were derived from 12.5 day old mouse embryos and were used at passage 1.
  • mice embryonic fibroblasts (3 to 4 X 10 6 as compared to 2 to 3 X 10 6 cells per 10 cm dish (Graves and Moreadith, 1993)) together with the use of 12.5 days' embryos markedly reduced the differentiation of the ES cells .
  • the trypsinization medium consisted of 0.1% collagenase, 1% chicken serum and 0.03% trypsin-EDTA (Gibco Cat. no. 25200) in phosphate buffered saline. This selective trypsinization medium allowed the selective passage of ES cells because mouse embryonic fibroblasts and trophectodermal cells detach more slowly from the culture dish than ES cells.
  • GM3 cells derived from Dutch Belted embryos by Graves and Moreadith (1993) , but maintained in culture conditions in Example 1, were used to generate chimeric offspring as described below. Blastocyst injection of the epitheloid colonies of the putative ES cells had previously never generated chimeric rabbits after injection into rabbit embryos (Table 1) . For further experiments described below, GM3 cells from passage 12 were maintained in improved culture conditions which stabilized the percentage of alkaline phosphatase positive, undifferentiated ES cells.
  • Blastocysts were recovered from the uterine horns 90 hours after mating, by flushing the uterine cavity with Dulbecco' s phosphate buffered saline supplemented with 3% bovine serum albumin (Cohn fraction V) plus 5% antibiotic/antimycotic solution (Gibco, Grand Island, NY) which had been pre-equilibrated at 39°C in a humidified atmosphere of 5% C0 2 in air.
  • Chimeras were generated by injection of both epitheloid alkaline phosphatase negative and the three dimensionally growing alkaline phosphatase positive ES cells into the blastocoel cavity of New Zealand White blastocyst (Table 2) .
  • a total of 287 New Zealand White blastocysts were injected with 20 to 300 cells from the GM3 cell line.
  • Blastocyst injections with GM3 cells were performed on a Zeiss inverted microscope with differential interference optics at a magnification of 250X. Micromanipulations were performed with Narashige micromanipulators as routinely employed for the mouse.
  • Percentages in parentheses are relative to numbers of blastocysts injected.
  • Superovulated Dutch Belted does were mated with Dutch Belted bucks.
  • the blastocysts were flushed from the uterine horns on day 5.5 (postcoitus instead of 4 or 5 days postcoitus) and rinsed with Dulbecco' s phosphate buffered saline supplemented with 3% bovine serum albumin (Cohn fraction V) plus 5% (v/v) antibiotic/antimycotic solution.
  • the blastocysts were kept in rabbit ES medium (described above) at 39°C in a 5% C0 2 incubator until further manipulation.
  • the inner cell mass was prepared manually out of the surrounding trophectoderm cells with 2 needles and placed individually in a 96 well culture dish (plated with 12.5 days old, passage 1 mouse embryonic fibroblasts with a density equivalent to 3 to 4 X 10 cells per 10 cm dish) .
  • the explanted inner cell masses were refed daily with the improved rabbit ES cell medium described above in which murine Leukemia Inhibitory Factor was replaced by human or rabbit Leukemia Inhibitory Factor. After 2 days, the inner cell mass outgrowth was easily freed from remaining trophectoderm cells by gently lifting the trophectoderm outgrowth with a beveled glass pipet off the underlying feeder layer and by aspirating it into the glass pipet .
  • the ES cells were passaged very gradually onto larger culture dishes at 4 to 5 days intervals, to maintain the ES cells at a very high density, another prerequisite to prevent differentiation and loss of pluripotency.
  • the feeder densities on the subsequent culture dishes was maintained at densities equivalent of 3 to 4 X 10 cells per 10 cm dish.
  • the rabbit ES cell lines obtained by this procedure are more similar to pluripotent murine ES cell lines than any of the rabbit ES variants previously reported.
  • the main characteristics are colony growth in three dimensions, high refractility and a small nuclear/cytoplasmic ratio. The most important characteristics are that after 10 passages, 80 to 90% of the ES cells remain undifferentiated as indicated by their positive staining for alkaline phosphatase ( Figure 3b) , and negative staining for human cytokeratin 18 and mouse vimentin, which are known markers of differentiation (Viebahn et al . , 1988; Piedrahita et al . , 1990) .
  • Roder JC (1993) Derivation of completely cell culture derived mice from early-passage embryonic stem cells Proc Natl Acad Sci USA 90:8424-8428.
  • Strojeck M, Reed MA, Hoover JL, Wagner TE (1990) A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocysts. Theriogenology 33:901-913.
  • Rabbit ES cells (GM3 line) , derived by Graves and Moreadith.
  • the belts are typical for the Dutch Belted strain from which the GM3 ES cell line was derived.

Abstract

The present invention relates to a rabbit embryonic stem (ES) cell line, comprising at least 70 %, preferably 80 to 90 % undifferentiated cells and obtainable by isolating the inner cell mass of 5.5 days postcoitus blastocysts and culturing them on feeder cells in rabbit ES medium. The invention further relates to further optimization of derivation and maintenance of the cell line and to the use thereof in inter alia generation of chimeric rabbits.

Description

PLURIPOTENT RABBIT EMBRYONIC STEM (ES) CELL LINES AND THEIR USE IN THE GENERATION OF CHIMERIC RABBITS
The present invention relates to novel rabbit embryonic stem (ES) cell lines and their use in the gene¬ ration of chimeric rabbits.
Gene targeting (via homologous recombination in embryonic stem (ES) cells) technology allows the manipulation of the genome in desired and defined ways (Capecchi, 1989; Robertson, 1987; Bradley, 1987) . Briefly, genes to be targeted are incorporated in plasmid transfer vectors and altered by replacement of some of their sequence with foreign DNA which encodes selectable markers (inactivation) or by a mutated gene sequence (targeted mutagenesis) . These inactivated or mutated genes are then introduced into ES cells (which each have the potential to develop into a complete animal) . Subsequently clones of ES cells in which the natural gene is replaced by the inactivated hybrid are selected in vitro, and these selected clones are introduced into normal embryos which are reimplanted. This process generates chimeric animals which are selected for germline transmission of the inactivated gene. Through breeding and selection, transgenic animals are then gene¬ rated which are deficient in the targeted ( "knocked-out" ) gene.
Completely ES cell derived mice can be generated utilising the recently developed technology to aggregate wild type or mutant ES cells with tetraploid embryos (Nagy et al . , 1993) . Alternatively ES cells can be used for introduction of genetic material by non- homologous recombination, allowing the study of genetic alteration in live animals.
The application of transgenic technologies and ES cell technologies for the alteration of gene function has provided animal models of important human diseases (for review cfr. Wilson, 1996; Rubin and Barsch, 1996) . However, at present this technology has only been successful in the mouse. Although useful for many applications, the mouse has significant restrictions (e.g. size and inability to generate the phenotype of human diseases) that limit its potential applications. Consequently, larger animal models to test the phenotypic consequences or loss-of-function mutations would be very valuable.
Presumptive pluripotential ES cells have been isolated in a number of additional species including hamster (Doetschman et al . , 1988) , pig (Evans et al . , 1990; Piedrahita et al . , 1990; Notarianni et al . , 1990; Talbot et al . , 1993) , sheep (Notarianni et al . , 1990) , cattle (Evans et al . ; Saito et al . , 1992) , mink (Sukoyan et al . , 1993) , rabbit (Graves and Moreadith, 1993) , rat (Iannaccione et al . , 1994), man (Bongso et al . , 1994) and primate (Thomson et al . , 1995) . However, only in the mouse and rat ES cells have been established in culture giving rise to chimeras following reintroduction into blastocysts, whereas all efforts in the rabbit and other species have failed to date.
Inner cell mass (ICM) cells freshly derived from rabbit blastocysts have been shown to allow the generation of chimeric rabbits following injection into recipient blastocysts (Gardner and Munro, 1974; Moustafa, 1974; Babinet and Bordenave, 1980) , whereas Yang et al . (1993) have reported the production of chimeric rabbits both from freshly isolated ICM and from ICM cells maintained in culture in vitro for 3 days.
However, in order to allow gene targeting by homologous recombination in ES cells, cell lines that can be kept in culture for a longer period of time and with demonstrated potential to generate chimeric animals are necessary for the production of offspring with targeted genetic alterations. Prior to the present invention, no such cell lines of animals other than mice and rats had been isolated.
The derivation of putative pluripotential rabbit ES cells was previously reported by Graves and Moreadith (1993) . Two principal cell types emerged follo¬ wing serial passage of explanted embryos . One type had morphology identical to primary outgrowths of trophecto- derm, cells that are responsible for embryo implantation. The second type appeared typically epitheloid and was presumed to represent rabbit ES cells (Figure 1) . Although these putative ES cells were able to generate embryoid bodies, consisting of multiple cell types representative of ectoderm, mesoderm and endoderm, they were unable to produce chimeric rabbits after introduction of the epitheloid cells into blastocysts from the New Zealand White (NZW) strain (Graves and Moreadith, 1993; Graves and Moreadith, unpublished results (Table 1) ) or after nuclear transfer into a denucleated New Zealand White zygote (Du et al . , 1995) . It was suggested that the inability to produce chimeras with these ES cells could have been due to a strain barrier. Nevertheless, the data in Table 1 demonstrate that no chimeric animals could be derived from any of the four tested epitheloid lines, each derived from a single inner cell mass.
Table 1: Results of rabbit embryo injection with putative ES cell lines (unpublished results, Graves and Moreadith)
cell line stage of #injections #born (%) chimeras (%) embryo
GM3 blastocyst 46 29(63) 0(0)
GM4 blastocyst 24 2 (8) 0(0)
GM8 morula 84 6 (7) 0(0) GM4 morula 14 5(35) 0(0)
Total 168 42 (25) 0(0) Niemann and Strelchenko (1994) also attempted to isolate and maintain pluripotent rabbit (California strain) ES cells but, although aggregation of the putative ES cells (maintained for a total of 12 passages) with the inner cell mass of the host blastocyst
(Chinchilla, Black Rex) was observed, generation of chimeric offspring was not documented. These putative ES cells were derived from rabbit embryos collected 4 days after mating. Thus, to date, all efforts to generate stable pluripotent rabbit ES cell lines, with the demonstrated potential to generate chimeric animals following injection into recipient blastocysts, have failed.
It is therefore the object of the invention to come to the improved derivation and maintenance of rabbit embryonic stem (ES) cells with demonstrated potential to generate chimeric rabbits following injection in recipient blastocysts, thus enabling the production of wild type or genetically altered offspring (via either homologous or non-homologous recombination, using for example gene or nuclear transfer) .
It was now found that a rabbit embryonic stem (ES) cell line, comprising at least 70%, preferably 80 to 90% undifferentiated cells is obtainable by isolating the inner cell mass of 5.5 days postcoitus blastocysts and culturing them on feeder cells in rabbit ES medium.
The rabbit ES medium according to the invention comprises high glucose Dulbecco' s Modified Eagle Medium, 4mM L-glutamine, 0.1 mM 2-mercaptoethanol, 148 units/ml penicillin G sodium, 148 microgram/ml streptomycin sulfate, 4 microgram/ml bovine insulin, 103 units/ml murine Leukemia Inhibitory Factor, 20% fetal bovine serum, 1.5% MEM non-essential amino acid solution.
The feeder cells are preferably mouse embryonic fibroblasts derived from 12.5 days old mouse embryos and used in a density of 3 to 4X106 cells per 10 cm petri dish. Preferably also a modified trypsinization method was used, which consists of the use of trypsinization medium comprising 0.1% collagenase, 1% chicken serum and 0.03% trypsin-EDTA in phosphate- buffered saline. This medium allowed the selective passage of ES cells because mouse embryonic fibroblasts and trophectodermal cells detach more slowly in this medium.
Cells according to the invention are recognisable by virtue of their following properties: three dimensional colony formation, positive staining for alkaline phosphatase and negative staining for cytokeratin 18 and vimentin after more than 10 passages.
The invention further relates to the use of the ES cell lines for the generation of chimeric rabbits, for example following blastocyst injection into recipient blastocysts or embryo aggregation or nuclear transfer.
The ES cell lines of the invention may also be used for gene alteration by homologous or non-homologous recombination or for the generation of rabbits with gene alteration via germline transmission.
The use or differentiation of cell lines accor¬ ding to the invention can lead to the study or isolation of (novel) genes.
The present invention thus leads to the improved derivation of pluripotent ES cells, their maintenance in culture over several passages, and their use for the successful generation of chimeric animals.
The derivation and maintenance of rabbit ES cells with demonstrated potential to generate chimeric rabbits following injection in recipient blastocysts will allow the generation of offspring capable of germline transmission of the targeted mutations following homologous or non-homologous recombination in these pluripotent ES cells. In addition, the pluripotency of the rabbit ES cells will allow to differentiate them into defined cell types enabling the study or isolation of novel genes . The invention will be illustrated in the following examples, that are not intended to limit the scope of the invention. Based on the present invention, several variants and improvements will be obvious to those skilled in the art .
EXAMPLE 1
Cell culture conditions
Starting from the ES cell line GM3 , derived from Dutch Belted rabbit embryos as described by Graves and Moreadith (1993) (Figure 1), cell culture conditions were developed which stabilized the percentage of undifferen-tiated ES cells, relative to the methods described by Graves and Moreadith (1993) . Thus, it became possible, for the first time, to generate chimeras after injection of ES cells into the blastocoel cavity of New Zealand White blastocysts, as will be demonstrated in Example 2.
Changes were made to the cell culture medium, the density of the mouse embryonic fibroblast (MEF) feeder layers, the age of the mouse embryos used to derive the MEFs, and the trypsinization medium used to dislodge cells for passage.
The culture medium used by Graves and Moreadith (1993) consisted of high glucose Dulbecco's Modified Eagle Medium, 4mM L-glutamine, 0.1 mM 2-mercaptoethanol, penicillin G sodium l48U/ml, and streptomycin sulfate 148 μg/ml .
According to the invention the following supplements were changed or added: 4 μg/ml bovine insulin, 103 units/ml of murine Leukemia Inhibitory Factor, 20% fetal bovine serum, 1.5% MEM non-essential amino acid solution.
The rabbit ES cells (1.5 to 3 X 106 cells per 10 cm petridish) were grown to subconfluency on mouse embryonic fibroblasts mitotically arrested with mitomycin and the ES cells were passaged every 4-6 days onto freshly prepared feeders (3 to 4 X 106 cells per 10 cm dish) . The ES cells were fed every day with the improved medium described above. Culture dishes were kept at 39°C in a humidified atmosphere of 5% C02 in air. The mouse embryonic fibroblast were derived from 12.5 day old mouse embryos and were used at passage 1. The increased density of the mouse embryonic fibroblasts (3 to 4 X 106 as compared to 2 to 3 X 106 cells per 10 cm dish (Graves and Moreadith, 1993)) together with the use of 12.5 days' embryos markedly reduced the differentiation of the ES cells .
This reduction of differentiation proved to be crucial, since only undifferentiated cells maintain the capacity to incorporate in the inner cell mass of a recipient embryo, a prerequisite to give rise to chimeric offspring.
Furthermore, an improved selective trypsinization method was used which allowed the removal of trophectodermal cells (which can induce ES cell differentiation) from the culture. The trypsinization medium consisted of 0.1% collagenase, 1% chicken serum and 0.03% trypsin-EDTA (Gibco Cat. no. 25200) in phosphate buffered saline. This selective trypsinization medium allowed the selective passage of ES cells because mouse embryonic fibroblasts and trophectodermal cells detach more slowly from the culture dish than ES cells.
EXAMPLE 2
Generation of chimeras
The GM3 cells, derived from Dutch Belted embryos by Graves and Moreadith (1993) , but maintained in culture conditions in Example 1, were used to generate chimeric offspring as described below. Blastocyst injection of the epitheloid colonies of the putative ES cells had previously never generated chimeric rabbits after injection into rabbit embryos (Table 1) . For further experiments described below, GM3 cells from passage 12 were maintained in improved culture conditions which stabilized the percentage of alkaline phosphatase positive, undifferentiated ES cells.
Sexually mature New Zealand White females were superovulated with six consecutive subcutaneous injections of porcine follicle stimulating hormone (FSH - 0.4, 0.4, 0.5, 0.5, 0.5, 0.5 mg) given 12 hours apart, followed by 75 IU of human chorionic gonadoptropin (hCG) given intravenously 10 hours after the last dose of FSH. Following the hCG injection, the females were mated with mature males of the same strain.
Blastocysts were recovered from the uterine horns 90 hours after mating, by flushing the uterine cavity with Dulbecco' s phosphate buffered saline supplemented with 3% bovine serum albumin (Cohn fraction V) plus 5% antibiotic/antimycotic solution (Gibco, Grand Island, NY) which had been pre-equilibrated at 39°C in a humidified atmosphere of 5% C02 in air.
Chimeras were generated by injection of both epitheloid alkaline phosphatase negative and the three dimensionally growing alkaline phosphatase positive ES cells into the blastocoel cavity of New Zealand White blastocyst (Table 2) . A total of 287 New Zealand White blastocysts were injected with 20 to 300 cells from the GM3 cell line. Blastocyst injections with GM3 cells were performed on a Zeiss inverted microscope with differential interference optics at a magnification of 250X. Micromanipulations were performed with Narashige micromanipulators as routinely employed for the mouse.
Between 5 and 10 embryos injected with GM3 cells were reimplanted into the proximal portion of each uterine horn of a recipient New Zealand White doe using a small incision and a sharpened glass pipette. This recipient doe had previously received 75 IU of hCG, 14 hours after the time of hCG injection in the donors. The reimplantation procedure was done under general anesthesia with a ketamine/xylazine mixture.
Table 2: Production of chimeras after injection of ES cells into the blastocoel cavity of New Zealand White blastocysts
#blasts injected #ES cells passage #born(%) #chimeras(%)
76 20-30 22 30 (41) 1(1)
24 50-100 15 31 (25) 1(1)
87 100-300 18 6(7) 1(1)
Total 287 67(23) 3(1)
Percentages in parentheses are relative to numbers of blastocysts injected.
This procedure resulted in an overall live birth rate of 23%. Since the ES cell line used was derived from the pigmented Dutch Belted strain, injection of GM3 ES cells into blastocysts from a nonpigmented New Zealand White strain will generate overt coat color formation in chimeras. As judged by coat color, three chimeric animals were obtained with one or more black belts, typical for the Dutch Belted strain. The percentage of chimerism varied between 10% to more than 50%, based upon contribution of the Dutch Belted pigmented coat. One of these chimeras was male (Figure 2a) , one female (Figure 2b) and one probably a hermaphrodite. These results constitute the first proof of principle that chimeric rabbits can be generated by blastocyst injection of ES cell lines maintained in culture and extensively (15 to 22 times) passaged. In retrospect chimerism appeared to be attributable to the three dimensionally growing alkaline phosphatase positive ES cells, as further detailed below.
Indeed, the frequency of chimera formation following injection of ES cells into the blastocoel cavity was low - only 4% of live born animals. This might have been due to several factors, including 1) infrequent incorporation of ES cells into the developing embryo due to the prominent void space in the mature blastocyst into which the ES cells were introduced, 2) an inherent incom¬ patibility of Dutch Belted ES cell lines with New Zealand White blastocysts, or 3) loss of pluripotency of the cell lines. Attempt to increase the frequency of delivery of ES cells to the developing inner cell mass by introducing the ES cells directly onto or into the developing inner cell mass, a prerequisite for incorporation into the subsequent embryo, did not result in a higher frequency or chimera formation. The use of Dutch White blastocysts (originating from the Dutch Belted strain by a natural point mutation) as recipients for ES cell injections also did not generate chimeras, thus eliminating the involvement of a strain barrier.
Additional experiments revealed that the absence of chimera formation with ES cells maintained in culture as described by Graves and Moreadith (1993) and the low efficiency with ES cells cultured as described in Example 1, starting from early passage GM3 cells was most likely due to the absence in the former and the low percentage in the latter of residual pluripotent ES cells. This was revealed by staining for alkaline phosphatase, which is present in undifferentiated cells, but rapidly lost upon differentiation (Benham et al . , 1981) . The occurrence of alkaline phosphatase positive cells in the original cell line was less than 1% after passage 10 (Figure 1) , al- though this frequency could be maintained under the improved culture conditions described herein. It appears that the flat epithelioid cell type (Figure 1) originally thought to represent putative ES cells (Graves and Moreadith, 1993) are mostly alkaline phosphatase negative, unable to incorporate in the inner cell mass of the recipient blastocyst, and unable to generate chimeric off-spring. Therefore new ES cell lines were derived as described in Example 3.
EXAMPLE 3 Improved derivation of ES cells
Improved methods for derivation of ES cells were developed which, in combination with the improved cell culture conditions, allowed the generation of five rabbit ES cell lines which consist of more than 80% undifferen-tiated alkaline phosphatase positive cells after 8 to 10 passages, as described below.
Superovulated Dutch Belted does were mated with Dutch Belted bucks. The blastocysts were flushed from the uterine horns on day 5.5 (postcoitus instead of 4 or 5 days postcoitus) and rinsed with Dulbecco' s phosphate buffered saline supplemented with 3% bovine serum albumin (Cohn fraction V) plus 5% (v/v) antibiotic/antimycotic solution. The blastocysts were kept in rabbit ES medium (described above) at 39°C in a 5% C02 incubator until further manipulation. The mucin coat and zona pellucida of the blastocysts were removed using acidified phosphate buffered saline (pH=2.5) and 0.5% pronase in phosphate buffered saline. The inner cell mass was prepared manually out of the surrounding trophectoderm cells with 2 needles and placed individually in a 96 well culture dish (plated with 12.5 days old, passage 1 mouse embryonic fibroblasts with a density equivalent to 3 to 4 X 10 cells per 10 cm dish) .
The explanted inner cell masses were refed daily with the improved rabbit ES cell medium described above in which murine Leukemia Inhibitory Factor was replaced by human or rabbit Leukemia Inhibitory Factor. After 2 days, the inner cell mass outgrowth was easily freed from remaining trophectoderm cells by gently lifting the trophectoderm outgrowth with a beveled glass pipet off the underlying feeder layer and by aspirating it into the glass pipet .
Only ES-like colonies, characterised by three dimensional growth were subsequently passaged onto new culture dishes. Therefor the 96 well was selectively trypsinized after 4 to 5 days with the trypsinization medium described above, thus allowing the selective passaging of ES cells and not of trophectoderm cells or mouse embryonic fibroblasts. The three dimensional growth typical of the improved- rabbit ES cells has not been noticed before and is apparently a novel characteristic of such cell lines. Only with the improved culture conditions and the use of 5.5 days old embryos, could three dimensional undifferentiated ES cell colonies be maintained at high frequency in culture. The ES cells were passaged very gradually onto larger culture dishes at 4 to 5 days intervals, to maintain the ES cells at a very high density, another prerequisite to prevent differentiation and loss of pluripotency. The feeder densities on the subsequent culture dishes was maintained at densities equivalent of 3 to 4 X 10 cells per 10 cm dish.
The rabbit ES cell lines obtained by this procedure (Figure 3) are more similar to pluripotent murine ES cell lines than any of the rabbit ES variants previously reported. The main characteristics are colony growth in three dimensions, high refractility and a small nuclear/cytoplasmic ratio. The most important characteristics are that after 10 passages, 80 to 90% of the ES cells remain undifferentiated as indicated by their positive staining for alkaline phosphatase (Figure 3b) , and negative staining for human cytokeratin 18 and mouse vimentin, which are known markers of differentiation (Viebahn et al . , 1988; Piedrahita et al . , 1990) . These properties stand in major contrast with those of the earlier putative ES cell line (Figure 1) , where less than 1% of the cells were undifferentiated as judged by alkaline phosphatase positive staining. This enormous increase in the percentage of undifferentiated cells (from 1% to 80-90%) in frequently passaged rabbit ES cells, should markedly increase the efficiency of chimeric rabbit generation by ES cell injection into blastocysts and allow the generation of chimeric rabbits containing targeted genetic alterations. REFERENCES
Babinet C, Bordenave GR (1980) ; Chimeric rabbits from immunosurgically-prepared inner cell mass transplantation. J Embryol Exp Morphoi 60:429-440. Benham FJ, Andrews FW, Knowles BB, Bronson DL, Harris H (1981) : Alkaline phosphatase isozymes as possible markers of differentiation in human testicular teratocarcinoma cell lines. Dev. Bio 88 :279-287. Bongso A, Fong C-Y, Ng S-C, Ratman S (1994) : Isolation and culture of inner cell-mass from human blastocysts. Hum Reprod 9:2110-2117. Bradley A (1987) : Production and analysis of chimeric mice. In: Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (Ed. Robertson EJ) , IRI Press Ltd., Oxford, 1987, pp. 113-151. Capecchi MR (1989) : Altering the genome by homologous recombination. Science 244:1288-1292. Doetschman T, Williams P, Maeda N (1988) : Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev Biol 127:224-227. Du F, Giles JR, Foote RH, Graves KG, Yang X, Moreadith RW (1995) : Nuclear transfer of putative rabbit embryonic stem cells leads to normal blastocyst development. J Reprod Fert 104:219-223. - Evans MJ, Notarianni E, Laurie S, Moor RM (1990) : Derivation and preliminary characterization of pluripotent cell lines from porcine and bovine blastocysts. Theriogenology 33:125-128. Gardner RL, Munro AJ (1974) : Successful construction of chimeric rabbit. Nature 250:146.
Graves KH, Moreadith RW (1993) : Derivation and characterization of putative pluripotential embryonic stem cells from preimplantation rabbit embryos. Mol Reprod Dev 36:424-433. - Iannaccone PM, Taborn GU, Garton RL, Caplice MD,
Brenin DR (1994) : Pluripotent embryonic stem cellε from the rat capable of producing chimeras . Dev Biol
163:288-292.
Johnson LV, Calarco PG, Siebert LS (1977) : Alkaline phosphatase activity in the preimplantation mouse embryo. J Embryol exp Morph 40:83-89.
Moustafa L (1974) : Chimeric rabbits from embryonic cell transplantation. Proc Soc Exp Biol 147:485-488.
Nagy, A, J Rossant, R Nagy, W Abromow-Newerly, and
Roder JC (1993) : Derivation of completely cell culture derived mice from early-passage embryonic stem cells Proc Natl Acad Sci USA 90:8424-8428.
Nieman H, Strelchenko N (1994) : Isol-ation of rabbit embryonic stem (ES) cell like cells. Theriogenology
41:265. Notarianni E, Galli C, Laurie S, Moor RM, Evans MJ
(1991) : Derivation of pluripotent, embryonic cell lines from the pig and sheep. J Reprod Fert Suppl
43 :255-260.
Notarianni E, Laurie S, Moor RM, Evans MG (1990) : Maintenance and differentiation in culture of pluripotential embryonic cell lines from pig blastόrysts. J Reprod Fert 40:51-56.
Piedrahita JA, Anderson GB, BonDurant RH (1990) : On the isolation of embryonic stem cells: Comparative behaviour of murine, porcine and ovine embryos.
Theriogenology 34:879-891.
Robertson EJ (1987) : Embryo-derived stem cell lines;
In/ Teratocarcinomas and Embryonic Stem Cells: A
Practical Approach (Ed. Robertson EJ) , IRI Press Ltd., Oxford, 1987, pp. 71-112.
Rubin EM, Barsh GS (1996) : Biological insights through genomics : mouse to man. J Clin Invest
97:275-280.
Saito S, Strelchenko N, Nieman H (1992) : Bovine embryonic stem cell-like cell lines cultured over several passages. Roux Arch Dev Biol 201:134-141.
Strojeck M, Reed MA, Hoover JL, Wagner TE (1990) : A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocysts. Theriogenology 33:901-913. Sukoyan MA, Golubitsa AN, Zhelezova Al , Shilov AG, Vatolin SY, Maximovsky LP, Andreeva LE, Mc Whir J, Pack SD, Bayborodin SI, Kerkis AY, Kizilova HI, Serov OL (1992) : Isolation and cultivation of blastocyst-derived stem cell lines from American mink. Mol Reprod Dev 33:418-431. Talbot NC, Caird ER jr, Vernon GP, Powell AM, Nel ND (1993) : Culturing the pig epiblast cells of the pig blastocysts. In Vitro Cell Dev Biol 29A:546-554. Thomson JA, Kalishman J, Golos TG, During M, Harris CP, Becker RA, Hearn JP (1995) : Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci USA 92:7844-7848.
Viebahn C, Lane BE, and Ramackers FCS (1988) Keratin and Vimentin expression in early embryogenesis of the rabbit embryo. Cell Tissue Research 253:553-562. Wilson JM (1996) : Animal models of human disease for gene therapy. J Clin Invest 97:1138-1141.
Yang X, Foote RH (1988) : Production of chimeric rabbits from morulae by a simple procedure. Gamete Res 21:345-351.
LEGENDS TO THE FIGURES
Fig. 1:
Rabbit ES cells (GM3 line) , derived by Graves and Moreadith.
A) phase contrast microscopy of the putative ES cells revealing a flat epitheloid phenotype
B) alkaline phosphatase staining of the putative
ES cells, showing a very low percentage (< 1 percent) of alkaline phosphatase positive cells (red) .
Fig. 2:
A) male chimera with one black belt .
B) female chimera, showing several black belts.
The belts are typical for the Dutch Belted strain from which the GM3 ES cell line was derived.
Fig. 3:
A) phase contract microscopy of a newly derived cell line using the improved cell culture and
ES derivation conditions described above.
B) alkaline phosphatase staining of a rabbit ES cell line derived using the improved eel culture and ES derivation conditions described above. The new ES cell line is characterized by three dimensional growth, high refractibility and 80 to 90% alkaline phosphatase positive staining.

Claims

1. Rabbit embryonic stem (ES) cell line, comprising at least 70%, preferably 80 to 90% undifferentiated cells and obtainable by isolating the inner cell mass of 5.5 days postcoitus blastocysts and culturing them on feeder cells in rabbit ES medium.
2. Rabbit embryonic stem (ES) cell line as claimed in claim 1, wherein the rabbit ES medium comprises high glucose Dulbecco' s Modified Eagle Medium, 4mM L-glutamine, 0.1 mM 2-mercaptoethanol, 148 units/ml penicillin G sodium, 148 microgram/ml streptomycin sulfate, 4 microgram/ml bovine insulin, 103 units/ml murine Leukemia Inhibitory Factor, 20% fetal bovine serum, 1.5% MEM non-essential amino acid solution.
3. Rabbit embryonic stem (ES) cell line as claimed in claims 1 or 2, wherein the feeder cells are
12.5 days old Mouse Embryonic Feeder cells in a density of 3 to 4 X 106 cells per 10 cm petri dish.
4. Rabbit embryonic stem (ES) cell line as claimed in claims 1, 2 or 3, wherein the ES cells are cultured over various passages and the ES cells are trypsinised before each passage with a selective trypsinization medium consisting of 0.1% collagenase, 1% chicken serum and 0.03% trypsin-EDTA in phosphate buffered saline.
5. Rabbit embryonic stem (ES) cell line as claimed in any one of the claims 1-4, characterised by three dimensional colony formation, positive staining for alkaline phosphatase and negative staining for cytokeratin 18 and vimentin after more than 10 passages.
6. Rabbit embryonic stem (ES) cell line as claimed in any one of the claims 1 to 5 for use in the generation of chimeric rabbits.
7. Rabbit embryonic stem (ES) cell lines as claimed in any one of the claims 1 to 5 for gene alteration by homologous or non-homologous recombination.
8. Rabbit embryonic stem (ES) cell lines as claimed in any one of the claims 1 to 5 for the generation of rabbits with gene alteration via germline transmission.
9. Rabbit embryonic stem (ES) cell lines as claimed in claims 1 to 5 for the study or isolation of (novel) genes.
10. Use of ES cell lines according to claims 1- 5 for the generation of chimeric rabbits.
11. Use as claimed in claim 10 for the generation of chimeric rabbits following blastocyst injection into recipient blastocysts or embryo aggregati¬ on or nuclear transfer.
12. Use of ES cell lines according to claims 1- 5 for gene alteration by homologous or non-homologous recombination.
13. Use of ES cell lines according to claims 1- 5 for the generation of rabbits with gene alteration via germline transmission.
14. Use or differentiation of cell lines accor- ding to claim 1-5 for the study or isolation of (novel) genes .
15. Rabbit ES medium, comprising high glucose Dulbecco's Modified Eagle Medium, 4mM L-glutamine, 0.1 mM 2-mercaptoethanol, 148 units/ml penicillin G sodium, 148 microgram/ml streptomycin sulfate, 4 microgram/ml bovine insulin, 103 units/ml murine Leukemia Inhibitory Factor, 20% fetal bovine serum, 1.5% MEM non-essential amino acid solution.
16. Selective trypsinization medium, consisting of 0.1% collagenase, 1% chicken serum and 0.03% trypsin-
EDTA in phosphate buffered saline.
PCT/EP1997/002323 1996-04-29 1997-04-29 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits WO1997041209A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU28929/97A AU2892997A (en) 1996-04-29 1997-04-29 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits
EP97922992A EP0907722A1 (en) 1996-04-29 1997-04-29 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits
JP9538604A JP2000508919A (en) 1996-04-29 1997-04-29 Pluripotent rabbit embryonic stem (ES) cell line and its use in developing chimeric rabbits

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP96201169.8 1996-04-29
EP96201169 1996-04-29
EP96203060 1996-11-04
EP96203060.7 1996-11-04
EP97200168 1997-01-22
EP97200168.9 1997-01-22

Publications (1)

Publication Number Publication Date
WO1997041209A1 true WO1997041209A1 (en) 1997-11-06

Family

ID=27237546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/002323 WO1997041209A1 (en) 1996-04-29 1997-04-29 Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits

Country Status (6)

Country Link
EP (1) EP0907722A1 (en)
JP (1) JP2000508919A (en)
CN (1) CN1217746A (en)
AU (1) AU2892997A (en)
CA (1) CA2252524A1 (en)
WO (1) WO1997041209A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999027076A1 (en) * 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
US6238922B1 (en) * 1999-02-26 2001-05-29 Stemcells, Inc. Use of collagenase in the preparation of neural stem cell cultures
WO2001044441A1 (en) * 1999-12-14 2001-06-21 Thermo Biostar, Inc. Stabilizing diluent for polypeptides and antigens
US6271436B1 (en) 1996-10-11 2001-08-07 The Texas A & M University System Cells and methods for the generation of transgenic pigs
EP1217071A1 (en) 2000-12-22 2002-06-26 Institut National De La Recherche Agronomique (Inra) Position-independent and tissue specific expression of a transgene in milk of transgenic animals
EP1294855A1 (en) * 2000-06-20 2003-03-26 ES Cell International Pte Ltd Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists
AU762112B2 (en) * 1997-11-25 2003-06-19 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
FR2834518A1 (en) * 2002-01-10 2003-07-11 Agronomique Inst Nat Rech METHOD FOR NUCLEAR CLONING IN RABBITS AND USES
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US9149026B2 (en) 2010-06-11 2015-10-06 Regeneron Pharmaceuticals, Inc. Production of fertile XY animals from XY ES cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9587220B2 (en) 2012-01-27 2017-03-07 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell
US10047345B2 (en) 2012-02-13 2018-08-14 Gamida-Cell Ltd. Culturing of mesenchymal stem cells with FGF4 and nicotinamide
US10196609B2 (en) 2013-03-08 2019-02-05 Kyoto University Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor
US10233426B2 (en) 2014-05-30 2019-03-19 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds
US10793874B2 (en) 2014-06-26 2020-10-06 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
US10893666B2 (en) 2015-09-17 2021-01-19 Regeneron Pharmaceuticals, Inc. Production of fertile XY female animals by silencing of genes on the Y chromosome

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2782596A1 (en) * 2009-12-01 2011-06-09 National Cancer Center Method for constructing chimeric rat using rat embryonic stem cells
WO2011071118A1 (en) 2009-12-09 2011-06-16 国立大学法人京都大学 Agent for promoting differentiation of pluripotent stem cells into cardiac muscle cells which includes nitrovin
EP2610249B1 (en) 2010-08-26 2017-10-11 Kyoto University Pluripotent stem cell cardiomyocyte differentiation-promoting agent
WO2015037706A1 (en) 2013-09-13 2015-03-19 国立大学法人京都大学 Compound promoting differentiation of pluripotent stem cells into cardiomyocytes
CA3017871A1 (en) 2016-03-18 2017-09-21 Kyoto University Method for freezing aggregates of pluripotent stem cell-derived cardiomyocytes
CN109609446B (en) * 2018-11-14 2020-11-03 广西大学 Culture solution and method for isolated culture of rabbit embryonic stem cells

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001541A1 (en) * 1988-08-04 1990-02-22 Amrad Corporation Limited In vitro propagation of embryonic stem cells
WO1994026884A1 (en) * 1993-05-14 1994-11-24 Biotechnology Research And Development Corporation Embryonic stem cells for making chimeric and transgenic ungulates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990001541A1 (en) * 1988-08-04 1990-02-22 Amrad Corporation Limited In vitro propagation of embryonic stem cells
WO1994026884A1 (en) * 1993-05-14 1994-11-24 Biotechnology Research And Development Corporation Embryonic stem cells for making chimeric and transgenic ungulates

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"METHODS IN ENZYMOLOGY", 1979, ACADEMIC PRESS, XP002026376 *
DU F. ET AL: "Nuclear transfer of putative rabbit embryonic stem cells leads to normal blastocyst development", JOURNAL OF REPRODUCTION AND FERTILITY, vol. 104, 1995, pages 219 - 223, XP000645112 *
GILES J.R. ET AL: "Pluripotency of cultured rabbit inner cell mass cells detected by isozyme analysis and eye pigmentation of fetuses following injection into blastocysts or morulae", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 36, 1993, pages 130 - 138, XP000645165 *
GRAVES K.H. ET AL: "Derivation and characterization of putative pluripotential embryonic stem cells from preimplantation rabbit embryos", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 36, 1993, pages 424 - 433, XP000645113 *
SCHOONJANS L. ET AL: "Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocysts", MOLECULAR REPRODUCTION AND DEVELOPMENT, vol. 45, December 1996 (1996-12-01), pages 439 - 443, XP000645114 *
STROJEK R.M. ET AL: "A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocytes", THERIOGENOLOGY, vol. 33, no. 4, 1990, pages 901 - 913, XP002026375 *

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271436B1 (en) 1996-10-11 2001-08-07 The Texas A & M University System Cells and methods for the generation of transgenic pigs
US6369294B1 (en) 1996-10-11 2002-04-09 Texas A&M University System Methods comprising apoptosis inhibitors for the generation of transgenic pigs
AU762112B2 (en) * 1997-11-25 2003-06-19 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
WO1999027076A1 (en) * 1997-11-25 1999-06-03 Arc Genomic Research Pluripotent embryonic stem cells and methods of obtaining them
US6238922B1 (en) * 1999-02-26 2001-05-29 Stemcells, Inc. Use of collagenase in the preparation of neural stem cell cultures
US7049141B1 (en) 1999-02-26 2006-05-23 Stemcells California, Inc. Use of collagenase in the preparation of neural stem cell cultures
WO2001044441A1 (en) * 1999-12-14 2001-06-21 Thermo Biostar, Inc. Stabilizing diluent for polypeptides and antigens
US6579688B2 (en) 1999-12-14 2003-06-17 Biostar, Inc. Stabilizing diluent for polypeptides and antigens
EP1294855A4 (en) * 2000-06-20 2004-09-15 Es Cell Int Pte Ltd Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists
US9080147B2 (en) 2000-06-20 2015-07-14 Es Cell International Pte Ltd. Culturing human embryonic stem cells with a noggin to generate cells lacking Pax-6 expression
EP1294855A1 (en) * 2000-06-20 2003-03-26 ES Cell International Pte Ltd Method of controlling differentiation of embryonic stem (es) cells by culturing es cells in the presence of bmp-2 pathway antagonists
EP2298867A3 (en) * 2000-06-20 2013-01-16 ES Cell International Pte Ltd. Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
EP2138583A1 (en) 2000-12-22 2009-12-30 Institut National De La Recherche Agronomique Position-independent and tissue specific expression of a transgene in milk of transgenic animals
EP1217071A1 (en) 2000-12-22 2002-06-26 Institut National De La Recherche Agronomique (Inra) Position-independent and tissue specific expression of a transgene in milk of transgenic animals
WO2003059053A3 (en) * 2002-01-10 2004-04-01 Agronomique Inst Nat Rech Rabbit nuclear cloning method and uses thereof
WO2003059053A2 (en) * 2002-01-10 2003-07-24 Institut National De La Recherche Agronomique Rabbit nuclear cloning method and uses thereof
FR2834518A1 (en) * 2002-01-10 2003-07-11 Agronomique Inst Nat Rech METHOD FOR NUCLEAR CLONING IN RABBITS AND USES
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US9885058B2 (en) 2010-06-11 2018-02-06 Regeneron Pharmaceuticals, Inc. Production of fertile XY female mice from XY mouse ES cells
US9398762B2 (en) 2010-06-11 2016-07-26 Regeneron Pharmaceuticals, Inc. Production of fertile XY female animals from XY ES cells
US9655351B2 (en) 2010-06-11 2017-05-23 Regeneron Pharmaceuticals, Inc. Production of fertile XY female animals from XY ES cells
US9149026B2 (en) 2010-06-11 2015-10-06 Regeneron Pharmaceuticals, Inc. Production of fertile XY animals from XY ES cells
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
US9587220B2 (en) 2012-01-27 2017-03-07 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell
US10047345B2 (en) 2012-02-13 2018-08-14 Gamida-Cell Ltd. Culturing of mesenchymal stem cells with FGF4 and nicotinamide
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US10196609B2 (en) 2013-03-08 2019-02-05 Kyoto University Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor
US10233426B2 (en) 2014-05-30 2019-03-19 Kyoto University Method for inducing cardiac differentiation of pluripotent stem cell with low-molecular compounds
US10793874B2 (en) 2014-06-26 2020-10-06 Regeneron Pharmaceuticals, Inc. Methods and compositions for targeted genetic modifications and methods of use
US10893666B2 (en) 2015-09-17 2021-01-19 Regeneron Pharmaceuticals, Inc. Production of fertile XY female animals by silencing of genes on the Y chromosome

Also Published As

Publication number Publication date
CN1217746A (en) 1999-05-26
EP0907722A1 (en) 1999-04-14
AU2892997A (en) 1997-11-19
JP2000508919A (en) 2000-07-18
CA2252524A1 (en) 1997-11-06

Similar Documents

Publication Publication Date Title
EP0907722A1 (en) Pluripotent rabbit embryonic stem (es) cell lines and their use in the generation of chimeric rabbits
Schoonjans et al. Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocysts
US10039269B2 (en) Methods and compositions for generating a mouse
Ledermann et al. Establishment of a germ-line competent C57BL/6 embryonic stem cell line
Saito et al. Bovine embryonic stem cell-like cell lines cultured over several passages
Wheeler Development and validation of swine embryonic stem cells: a review
Baharvand et al. Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains
US6436701B1 (en) Derivation of pluripotential embryonic cell lines from ungulate species
Strelchenko Bovine pluripotent stem cells
Dattena et al. Isolation, culture, and characterization of embryonic cell lines from vitrified sheep blastocysts
Sukoyan et al. Establishment of new murine embryonic stem cell lines for the generation of mouse models of human genetic diseases
US6103523A (en) Pluripotent rabbit cell lines and method of making
Anderson Isolation and use of embryonic stem cells from livestock species
Mizutani et al. Propagation of senescent mice using nuclear transfer embryonic stem cell lines
US20070250943A1 (en) Construction of Chimera Using En Cells
KR20090017597A (en) Preantral follicle-derived embryonic stem cells
Modliński et al. Embryonic stem cells: developmental capabilities and their possible use in mammalian embryo cloning
WO1995006716A1 (en) Rat pluripotent embryonic stem cells and method of obtaining and using same
Strelchenko Bovine Pluripotent stem cells for transgenic vectors
Kim et al. Efficient method for generating homozygous embryonic stem cells in mice
Peli et al. Comparison of aggregation and injection techniques in producing chimeras with embryonic stem cells in mice
KR100250599B1 (en) H3 embryonic stem cell line and process for preparing a transgenic mouse by using same
Gardner Pluripotential stem cells from vertebrate embryos: present perspective and future challenges
US20030124720A1 (en) Conditioned culture media
Panasophonkul et al. Establishment of porcine embryonic stem-like cells from parthenogenetic and in vivo derived embryos

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97194183.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2252524

Country of ref document: CA

Ref document number: 2252524

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997922992

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1997922992

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997922992

Country of ref document: EP